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Abstract During latency, Epstein Barr virus (EBV) genome, as
an episome, is attached to the nuclear matrix (NM) via the
latent origin of replication ori P. Within this element, we have
found that a region, 580 bp long, encompassing the replicator
DS element, shows the strongest a⁄nity for the NM. In addi-
tion, by cross-linking with cis-diamminedichloroplatinum, we
have identi¢ed two NM proteins with an apparent molecular
weight of 85 and 60 kDa that, with high a⁄nity and speci¢city,
bind ori P. These proteins are not induced by EBV infection, but
their interaction with ori P is lost upon induction of EBV lytic
cycle. These data strongly suggest that the binding of ori P to
speci¢c components of the NM is required for EBV latent rep-
lication.
0 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
During latency, Epstein Barr virus (EBV) genome, as an
episome, is replicated only once per cell cycle by the cellular
enzymes, when the infected cells proliferate [1]. The latent
origin of replication ori P and its binding protein EBNA1
are the only two viral components required for the replication.
ori P is composed of two cis-acting elements, the family of
repeats (FR) and the region of dyad symmetry (DS), which
are separated by approximately 1 kb of DNA [2,3]. The func-
tional component FR, an array of 20 EBNA1 binding sites,
provides the mitotic stability of episomes by tethering them,
via EBNA1, to human chromosomes [4,5]. However, replica-
tion initiates at or near DS, a 120 bp region that contains four
EBNA1 binding sites and therefore represents the replicator
of ori P [6,7]. Recent data indicate that replicator DS uses
essentially the same mechanisms and factors that operate at
the replication origins of cellular chromosomes by recruiting
cellular DNA origin recognition complex and replication li-
censing complex MCM [8,9].
In the eukaryotic nucleus, chromosomal DNA is organized
into distinct, topologically independent loops of variable size
[10,11] that de¢ne non-overlapping territories where DNA
and RNA metabolisms are con¢ned. These loops are an-
chored at their bases to a proteinaceous framework generally
referred to as the nuclear matrix (NM) or sca¡old [12]. The
DNA specialized elements involved in the binding of chroma-
tin loops to the NM, termed sca¡old or matrix attachment
regions (S/MARs), may be up to a few hundred nucleotides in
length, do not share a strictly conserved consensus sequence,
but often contain AT-rich stretches and clusters of topoiso-
merase II cleavage sites [13,14]. S/MARs have been found
close to promoters, enhancers and origins of replication, sug-
gesting they may serve to bring various cis-responsive ele-
ments close to matrix-bound DNA and RNA enzymatic ma-
chineries [15^17].
It is generally acknowledged that viral replication and ex-
pression occur in close association with the NM [18^23]; this
association is di¡erent for each virus, involving either viral
genome sequences or virus-codi¢ed proteins.
Previous studies carried out in Raji cells have shown that
the binding activity of EBV genome to the NM resides in a
5.2 kb region of DNA, covering the latent origin of replica-
tion ori P and the genes for the small viral RNAs (EBERs)
[19]. Moreover, we have reported that also the lytic origin of
replication ori Lyt binds the NM, following activation of the
EBV lytic cycle [24].
In the present study we set out to investigate the molecular
features of ori P binding to the NM of Raji cells. To this end,
we aimed at de¢ning which regions within ori P have the
highest a⁄nity for the NM and searched for NM proteins
involved in ori P binding.
We report here that a 580 bp sequence, encompassing the
DS element of ori P, shows the highest S/MAR activity. In
addition, by cross-linking with cis-diamminedichloroplatinum
(cis-DDP) on intact nuclei, we identi¢ed by Southern^Western
blot assay two cross-linked NM proteins, with an apparent
molecular weight of 85 and 60 kDa, respectively, that bind ori
P with high a⁄nity.
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2. Materials and methods
2.1. Cell culture and lytic cycle induction
Raji and Ramos cells, derived respectively from an EBV-positive
and an EBV-negative Burkitt’s limphoma, were cultured in RPMI
1640 medium containing 5% fetal calf serum and antibiotics, in a
5% CO2 atmosphere and maintained at a cell density of 3.5U105/
ml. To quantitatively induce an EBV lytic cycle (more than 60% of
the cells positive for EBV early antigens), Raji cells were treated as
previously described [24].
2.2. Preparation of nuclei
Nuclei from Raji and Ramos cells have been isolated as described
in [24], except for the addition of protease inhibitors phenylmethyl-
sulphonyl£uoride (PMSF), aprotinin and leupeptin (1 mM, 1 Wg/ml
and 0.5 Wg/ml, respectively) to all the bu¡ers used for nuclei isolation.
2.3. In vitro binding of end-labeled ori P fragments to nuclear matrices
The origin of replication ori P obtained as described below, was
digested with restriction enzymes NcoI and EcoRV for 3 h at 37‡C.
The DNA fragments were subsequently digoxigenin (DIG) 3P-end-
labeled (Roche Diagnostics, USA) according to the manufacturer’s
protocol. Nuclei (about 25 Wg DNA) were processed for NM prepa-
ration by the LIS extraction procedure and the resulting nuclear scaf-
folds used for in vitro binding assays as previously described [25], in
the presence of 50 ng/ml DIG-end-labeled ori P fragments, non-spe-
ci¢c competitor DNA (sonicated herring sperm DNA, 1^6 Wg/ml) and
30 U each of EcoRV, EcoRI and NcoI restriction enzymes. A centri-
fugation at 3200Ug for 15 min at 4‡C was used to separate solubilized
DNA from matrix-bound DNA. After protein digestion, puri¢ed
DNA was subjected to electrophoresis on 1.5% agarose gel and trans-
ferred to nylon membrane. DIG-end-labeled ori P fragments were
visualized by chemiluminescent detection (Roche Diagnostics).
As a control for the binding assay, pTZ-E20 plasmid [26] was
digested with DdeI/EcoRI. The resulting fragments were DIG-end-
labeled and tested for their binding activity to Raji NM under the
same conditions used for ori P fragments.
2.4. EBV DNA probes
Ampli¢cation of ori P, as well as those of the regions included in
the BamHI B and BamHI Z fragments of the EBV genome, was
performed by polymerase chain reaction (PCR) with the primers
and according to the conditions previously reported [24]. Plasmid
pTZ-E20 contains a 2.2 kb EcoRI fragment derived from the human
INFL SAR element [27].
For Southern^Western experiments, 10 pmol 3P-OH ends of each
DNA probe were DIG-labeled by tailing reaction (Roche Diagnos-
tics). Label e⁄ciency of the di¡erent DNA probes was comparable as
judged after electrophoresis, blotting and colorimetric detection.
2.5. Nuclei cross-linking by cis-DDP II
Nuclei (200^400 A260 units) obtained as described in [24], were
sedimented by centrifugation at 3000Ug for 20 min at 4‡. cis-DDP
II cross-linking procedure was carried out as described in [28] with 0.5
mM cis-DDP for 1 h at 37‡C with gentle shaking. NM preparations
were performed as described in [25]. The histone-depleted nuclei were
digested with EcoRI, BamHI and HindIII restriction enzymes (2 U/Wg
DNA), for 3 h at 37‡C. Nuclear sca¡olds were sedimented by centri-
fugation at 3000Ug for 10 min at 4‡C.
2.6. Isolation of cross-linked matrix proteins
Isolation of cross-linked matrix proteins was performed as de-
scribed in [29]. Usually, about 100 Wg of cross-linked NM-bound
DNA per mg of nuclear DNA were obtained. Based on OD readings,
hydroxyhapatite (HTP, DNA grade; Bio-Rad) was added to the
cross-linked complexes in the ratio of 1 g/200 A260 units. Cross-linked
NM proteins were eluted from HTP by thiourea treatment [29], dia-
lyzed against 30 mM Tris, pH 8, 1 mM PMSF and then concentrated
by Microcon (Millipore).
2.7. Southern^Western blotting
Cross-linked NM proteins derived from equivalent amounts of
DNA (as judged by A260 readings performed before binding to
HTP) were electrophoresed on a 10% acrylamide gel, transferred
onto PVDF membrane in a bu¡er consisting of 10 mM CAPS and
renatured in guanidine hydrocloride [30]. The DNA binding protein
blot assay was carried out as previously described [31] with 40 ng/ml
of DIG-tailed DNA probes in the presence of di¡erent amounts of
sonicated herring sperm competitor DNA. DNA-bound proteins were
visualized by enzyme-catalyzed color reaction (Roche Diagnostics).
2.8. Western blotting
Membranes used for the Southern^Western blotting experiments
were subsequently incubated with the following antibodies: telomeric
repeat binding factor 2 (TRF2) goat polyclonal antibodies (Imgenex)
was used at a 1:250 dilution; anti-EBNA 1 monoclonal antibodies
(Cyto-Bar, The Netherlands), anti SAF-A rabbit serum, anti-lamin B2
monoclonal antibodies (AbCam, UK), anti-lamins D/E antiserum,
anti-poly(ADP-ribose)polymerase (PARP) monoclonal antibodies
(Alexis), were used each at a 1:1000 dilution. Secondary antibodies,
horseradish peroxidase-linked anti-mouse, anti-rabbit and anti-goat/
sheep, were used at a 1:5000 dilution. Chemiluminescent detection of
the positive bands was performed by ECL Plus Western blotting re-
agents (Amersham Pharmacia Biotech), according to the manufactur-
er’s protocol.
3. Results
3.1. Binding of ori P restriction fragments to Raji nuclear
matrices
In order to assess which sequences within EBV latent origin
of replication would show the highest a⁄nity for the NM, we
have generated by PCR a probe, 1903 bp long, corresponding
to region 7300^9203 of the B95.8 EBV genome [32] that rep-
resents the ori P consensus sequence. This DNA region con-
tains both the FR and the DS element of EBV latent origin of
replication.
As is shown in Fig. 1A, digestion of the puri¢ed ampli¢ca-
tion product with NcoI and EcoRV restriction enzymes gen-
erates four fragments, two containing the FR and the DS
elements respectively, and two covering a stretch of about
960 bp, dispensable for ori P function. Fig. 1B shows the
analysis of the distribution of ori P 3P end-labeled fragments,
retained on the NM (M) or released in the supernatant (S). In
the absence of competitor DNA all of them are largely asso-
ciated to the NM. However, with increasing amounts of non-
speci¢c competitor DNA, only the 372 and 208 bp fragments
are retained on the matrix.
To verify that the partition of ori P fragments between the
NM and the supernatant was truly dependent on MAR activ-
ity, we analyzed in a similar experiment the distribution of the
fragments originating from a DdeI/EcoRI digestion of pTZ-
E20 plasmid. Because the binding potential to the NM de-
creases below 300 bp [33], fragments of 1091, 655, 540 and
409 bp from the vector and of 527, 414 and 411 bp from the
IFNL SAR insert were considered. Fig. 1C shows that in an in
vitro binding assay, the bands retained on the NM even in the
presence of the highest concentration of competitor DNA
localize with fragments that include IFNL SAR DNA. In
contrast, vector DNA fragments of 1091 and 655 bp are e⁄-
ciently competed o¡ the NM in the presence of increasing
concentrations of non-speci¢c DNA.
3.2. Identi¢cation of cross-linked NM proteins bound by ori P
DNA-binding NM proteins were obtained from nuclei of
latently infected Raji cells incubated with cis-DDP and pro-
cessed as summarized in Fig. 2. Hybridization of cross-linked
NM proteins with DIG-labeled ori P probe showed that two
species with a molecular weight of about 85 and 60 kDa,
respectively, were strongly recognized by ori P in the presence
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of 10 000-fold excess of non-speci¢c competitor DNA (Fig. 3).
The association of ori P to these NM components appears to
be highly speci¢c, since sequences of the BamHI Z and Bam-
HI B regions of EBV genome did not bind any NM protein,
even in the presence of low concentrations of competitor
DNA (data not shown).
3.3. ori P-bound NM proteins are not induced by EBV infection
In order to assess whether cross-linked NM proteins specif-
ically recognized by ori P in latently infected Raji cells were
related to viral infection, ori P binding was tested on similar
protein preparations obtained from induced Raji cells as well
as from EBV-negative Ramos cells. Fig. 4A, showing the
Coomassie staining of NM proteins recovered from equivalent
amounts of nuclear DNA, indicated that the pattern related to
cross-linked NM proteins isolated from latently infected Raji
cells or from EBV-negative Ramos cells are substantially sim-
ilar. Conversely, the protein components of induced Raji cells
are less represented, with more species migrating at low mo-
lecular weight. Fig. 4B clearly shows that in Ramos cells, ori P
recognized the 85 and 60 kDa NM components also detected
in latently infected Raji cells, indicating that these protein
species are neither codi¢ed, nor induced by EBV infection.
In contrast, EBV latent origin of replication did not bind
the 85 and 60 kDa proteins in similar preparations of induced
Raji cells.
3.4. Identi¢cation of ori P binding proteins
To identify the NM proteins detected by ori P, blots ¢rst
used for Southern^Western experiments were re-hybridized
with a number of antibodies, either for cellular proteins
known to bind EBV latent origin of replication, or for abun-
dant S/MAR binding NM proteins, with molecular weights in
the range of 90 and 60 kDa.
Among the cellular proteins recently identi¢ed by a⁄nity
chromatography to bind the DS element of ori P in an
EBNA1-dependent manner [34], TRF2 has an approximate
Fig. 2. Scheme of the experimental procedures devised to obtain
cross-linked NM proteins.
Fig. 1. S/MAR activity of ori P restriction fragments. A: 1.9 kb re-
gion of ori P with underneath the sites of the two cis-acting compo-
nents FR and DS. The size and position of the fragments obtained
by NcoI/EcoRV restriction of the PCR-generated ori P amplicon are
shown by open boxes. B: In vitro binding of 6 ng of 3P end-labeled
ori P fragments (input) to NM, in the absence or presence of in-
creasing amounts of non-speci¢c competitor DNA (see Section 2).
NM-associated (M) and soluble (S) DNA fractions were subjected
to electrophoresis, blotting and chemiluminescent detection. C: In
vitro binding of DdeI/EcoRI-digested pTZ-E20 plasmid. Labeled
with an asterisk are the fragments derived from the IFNL SAR in-
sert.
Fig. 3. Southern^Western blot of NM protein with ori P. Cross-
linked NM proteins from latently infected Raji cells were hybridized
with DIG-labeled ori P probe without or with non-speci¢c competi-
tor DNA. The detection of the positive bands was performed by al-
kaline phosphatase-catalyzed color reaction. The arrowheads indi-
cate ori P-bound proteins with molecular weights of about 85 and
60 kDa. These results were con¢rmed by more than three indepen-
dent experiments.
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size of 66 kDa and the apoptotic form of PARP has a mo-
lecular weight of about 86 kDa. Among NM DNA-binding
proteins, SAF-A, a very abundant component of the NM,
presents a cleavage product of about 90 kDa [35] and the
lamins of the B-type (B1, B2 and lamins D/E) the only ones
expressed in Raji cells [36], have molecular masses ranging
between 64 and 68 kDa. Moreover, because virus-encoded
ori P binding protein EBNA1 has a molecular weight that
varies considerably (from 69 to 94 kDa) depending on the
EBV-infected cell line [37], and because it might co-purify
with ori P regions bound to the NM, hybridization of the
blots with EBNA1-speci¢c antibodies was also evaluated.
Fig. 5 shows the results of the Western blots carried out
with the di¡erent antibodies on Raji cross-linked NM proteins
previously tested for ori P binding.
The data obtained clearly indicate that none of the proteins
revealed by the speci¢c antibodies co-migrates with either the
85 or the 60 kDa ori P binding proteins detected by Southern^
Western assays. In particular, SAF-A and PARP were both
present with the full forms of the proteins (120 and 116 kDa,
respectively) and EBNA1 antibodies highlighted in these cells,
a band with an apparent molecular weight of 70 kDa.
4. Discussion
A growing number of studies have been investigating the
functional role that speci¢c EBV DNA sequences, within ori
P, play in the replication and segregation of the viral genomes.
It is becoming clear that at least three viral components, the
ori P maintenance element FR, the replicator element DS, and
the viral protein EBNA1 interacting with them, are involved
in these processes. However, because the properties of EBV
plasmid suggest that viral DNA synthesis and expression is
linked to the cellular mechanisms that govern genomic DNA
replication and transcription, much e¡ort is currently ad-
dressed to identify the cellular factors possibly interacting
with ori P. In this respect, a major role seems to be played
by the NM, since it has been demonstrated to be responsible
for the anchorage of EBV origins of replication [19,24].
In latently infected Raji cells a 5.2 kb region of EBV ge-
nome, containing ori P and the genes for the small viral
RNAs (EBERs), has previously been shown to be associated
with the NM [19]. The fairly large size of this region required
a more detailed analysis of the DNA sequences involved in ori
P interaction with the NM. Therefore, we set up to determine
the core of the viral S/MAR element by subjecting di¡erent
functional regions of ori P to in vitro re-association with iso-
lated sca¡old.
By in vitro binding experiments, we report here that two ori
P fragments, one 208 bp long, encompassing the DS element,
and the one upstream, with a size of 372 bp, containing se-
quences dispensable for replicative function, show the stron-
gest S/MAR activity. The selective association of IFNL SAR
fragments to Raji NM, in a similar binding assay, validates
the results obtained with the di¡erent ori P regions. It is well
known that the interactions of S/MARs with the nuclear scaf-
fold are substantially di¡erent from well characterized pro-
tein^DNA interactions that involve a speci¢c DNA consensus
Fig. 4. ori P binding to cross-linked NM proteins from Raji and
Ramos cells. A: Cross-linked NM proteins related to equivalent
amounts of DNA (see Section 2), obtained from latently infected
(C), induced (I) Raji cells and from EBV-negative Ramos cells, were
electrophoretically separated and stained by Coomassie R 250.
B: Southern^Western blot carried out with DIG-labeled ori P probe
in the presence of 400 Wg/ml of unlabeled non-speci¢c competitor
DNA. Positive bands were detected as in Fig. 3. Arrowheads indi-
cate the 85 and 60 kDa proteins.
Fig. 5. Western blots of cross-linked NM proteins with speci¢c anti-
bodies. Cross-linked NM proteins isolated from latently-infected
Raji cells previously hybridized with ori P were incubated with spe-
ci¢c antibodies according to the conditions described in Section 2.
Detection of the positive bands was performed by chemiluminescent
assay. Full arrowheads indicate the position of the related proteins;
empty arrowheads indicate the position of the 85 and 60 kDa pro-
teins highlighted by ori P binding.
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sequence [13,27,38]. However, most S/MARs of cellular DNA
share di¡erent properties such as A^T-rich regions with pre-
dominance of the sequence ATATTT [33], topoisomerase II
sites [39], unusual DNA structures such as tracts with a nar-
row minor groove [40], base unpairing DNA regions [41,42]
or DNA bends [43]. Some of these features seem also to char-
acterize the S/MAR of EBV latent origin of replication. A
computer program (MAR-Wiz, Futuresoft Corporation)
that considers a number of properties for predicting MAR
activity has revealed the presence of two kinked DNA
stretches and one topoisomerase II site in the 372 and one
topoisomerase II site in the 208 bp fragment. In addition, the
ATATTT motif occurs ¢ve times in the 372 bp fragment with
83% identity, suggesting that a cooperative e¡ect of multiple
sites might contribute to determine the higher a⁄nity for the
NM.
cis-DDP has scarce propensity to form protein^protein
complexes while it very e⁄ciently induces the formation of
DNA^protein cross-linkages with low reactivity towards his-
tones [29]. For these features, it represents a highly suitable
cross-linking agent to select those NM proteins that most
likely bind the DNA ‘in vivo’.
We report here the identi¢cation of two NM proteins, of
about 85 and 60 kDa respectively, that by Southern^Western
technique reproducibly bind ori P with high a⁄nity and spec-
i¢city. Similar results were obtained when the NM isolation
procedure was performed by high salt extraction of the nuclei
[44] (data not shown). Because ori P recognizes the 85 and 60
kDa proteins also in NM preparations derived from EBV-
negative Ramos cells, these proteins appear to be constituents
of the NM, independently of the viral infection.
It is intriguing to observe that ori P did not bind these two
protein species when cross-linked NM proteins were isolated
from induced Raji cells (see Fig. 4B). It has been reported that
EBV lytic cycle gene expression protects the infected cells
from apoptosis induced by lytic cycle activators [45]. Our
results con¢rm this ¢nding, since a substantial decrement in
the concentration of SAF-A and poly(ADP-ribose)polymerase
1 (PARP1) was measured after induction of the EBV lytic
cycle, in the absence of the related apoptotic forms (unpub-
lished data). Because also under our experimental conditions
induced Raji cells appear to elude apoptosis, the lack of ori P
binding to the 85 and 60 kDa species in the NM of these cells
cannot depend on cell death-related degradation of nuclear
proteins. A likely possibility could be that profound changes
in NM composition/architecture take place during the early
phases of EBV productive infection. Ongoing studies are ad-
dressed to verify this hypothesis.
In an attempt to characterize the 85 and 60 kDa proteins,
we have used antibodies directed to main components of the
NM, telomere-associated proteins and proteins possessing
PARP activity that have been recently found to bind the
DS element in an EBNA1-dependent manner [34]. Because
the 85 or the 60 kDa proteins are not identi¢able with pre-
viously characterized ori P binding proteins, nor with the
major constituents of the NM, they might represent speci¢c
NM components involved in EBV anchorage and replication
during the latent cycle of infection.
Ongoing studies, aimed to purify and characterize these
proteins, will provide the tools to investigate the molecular
features and the functional role of ori P interaction with the
NM.
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